The company has rebounded from a net loss of US$1.3m to a net profit of US$0.6m.
Pasture Holdings rebounded from a net loss of $1.7m (US$1.3m) to a net profit of $0.73m (US$0.6m) in FY 2024.
Revenue for the period surged 44.9% year-on-year (YoY) to $18.3m (US$14.0m), driven by a 43..7% YoY growth in its pharmaceutical business which recorded a revenue of $18.2m (US$13.9m) with new customer acquisitions and more orders from existing customers.
The mask and medical supplies business also grew 300% to $201,434 (US$154,000) from $58,860 (US$45,000) in FY 2023.
Meanwhile, gross profit more than doubled to $4.6m (US$3.5m) due to higher revenue and related operational efficiencies achieved.
Pasture Holdings maintains a positive outlook amidst favourable structural trends such as the ageing global population, an enlarged cold chain warehouse capacity, and potential growth in new non-core business